Laboratory of Biosignaling and Therapeutics, KU Leuven Department of Cellular and Molecular Medicine, University of Leuven, 3000 Leuven, Belgium.
Laboratory of Biosignaling and Therapeutics, KU Leuven Department of Cellular and Molecular Medicine, University of Leuven, 3000 Leuven, Belgium.
Cell Chem Biol. 2023 Dec 21;30(12):1666-1679.e6. doi: 10.1016/j.chembiol.2023.07.018. Epub 2023 Aug 24.
An emerging strategy for the therapeutic targeting of protein phosphatases involves the use of compounds that interfere with the binding of regulatory subunits or substrates. However, high-throughput screening strategies for such interfering molecules are scarce. Here, we report on the conversion of the NanoBiT split-luciferase system into a robust assay for the quantification of phosphatase subunit and substrate interactions in cell lysates. The assay is suitable to screen small-molecule libraries for interfering compounds. We designed and validated split-luciferase sensors for a broad range of PP1 and PP2A holoenzymes, including sensors that selectively report on weak interaction sites. To facilitate efficient hit triaging in large-scale screening campaigns, deselection procedures were developed to eliminate assay-interfering molecules with high fidelity. As a proof-of-principle, we successfully applied the split-luciferase screening tool to identify small-molecule disruptors of the interaction between the C-terminus of PP1β and the ankyrin-repeat domain of the myosin-phosphatase targeting subunit MYPT1.
一种新兴的蛋白磷酸酶治疗靶点策略涉及使用干扰调节亚基或底物结合的化合物。然而,用于此类干扰分子的高通量筛选策略却很少。在这里,我们将 NanoBiT 分裂萤光素酶系统转换为一种强大的测定方法,用于定量细胞裂解物中磷酸酶亚基和底物的相互作用。该测定方法适用于筛选小分子文库中的干扰化合物。我们设计并验证了适用于广泛的 PP1 和 PP2A 全酶的分裂萤光素酶传感器,包括选择性报告弱相互作用位点的传感器。为了在大规模筛选活动中有效地进行命中分类,我们开发了选择程序,以高保真度消除具有高干扰性的测定分子。作为原理验证,我们成功地将分裂萤光素酶筛选工具应用于鉴定小分子破坏物,这些小分子破坏物可干扰 PP1β 的 C 末端与肌球蛋白磷酸酶靶向亚基 MYPT1 的锚重复结构域之间的相互作用。